We are live on ! Find out more

SPHS

Sophiris Bio, Inc.

SPHS

Delisted

SPHS was delisted on the 11th of March, 2020.

20 hedge funds and large institutions have $5.82M invested in Sophiris Bio, Inc. in 2015 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 6 increasing their positions, 2 reducing their positions, and 2 closing their positions.

New

Increased

Maintained

Reduced

Closed

687% more capital invested

Capital invested by funds: $739K → $5.82M (+$5.08M)

300% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 2

200% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 2

43% more funds holding

Funds holding: 14 → 20 (+6)

Holders

Holders Change

Holders Change %

+42.86%

% of All Funds

0.52%

Holding in Top 10

–

Holding in Top 10 Change

–

Holding in Top 10 Change %

–

% of All Funds

–

New

Increased

Reduced

Closed

Calls

–

Puts

–

Net Calls

–

Net Calls Change

–

Top Buyers

Rank	Fund	Capital Flow
1	RSCM Rock Springs Capital Management Baltimore, Maryland	+$930K
2	PAI Palo Alto Investors Palo Alto, California	+$448K
3	Morgan Stanley New York	+$244K
4	Vanguard Group Malvern, Pennsylvania	+$194K
5	VKH Virtu KCG Holdings New York	+$23.5K

Top Sellers

Rank	Fund	Capital Flow
1	Royal Bank of Canada Toronto, Ontario, Canada	-$12.4K
2	AIG American International Group New York	-$9K
3	Citigroup New York	-$78

#	Name	Holding	Trade Value	Shares Change	Change in Stake
1	BC 1 Boxer Capital San Diego, California	$1.78M	+$1.48M	+1,000,000	New
2	RSCM 2 Rock Springs Capital Management Baltimore, Maryland	$1.14M	+$930K	+628,563	New
3	GCM 3 Gruss Capital Management New York	$958K	–	–	–
4	PAI 4 Palo Alto Investors Palo Alto, California	$879K	+$448K	+302,400	+158%
5	5 Morgan Stanley New York	$389K	+$244K	+165,174	+308%
6	6 Vanguard Group Malvern, Pennsylvania	$312K	+$194K	+131,110	+318%
7	LWAC 7 Laurel Wealth Advisors (California) Solana Beach, California	$151K	+$125K	+84,600	New
8	AIM 8 Alambic Investment Management Belvedere, California	$65K	+$54.3K	+36,700	New
9	9 Bank of New York Mellon New York	$31K	–	–	–
10	VKH 10 Virtu KCG Holdings New York	$28K	+$23.5K	+15,859	New
11	11 UBS Group Zurich, Switzerland	$23K	+$19K	+12,830	New
12	12 Two Sigma Advisers New York	$22K	+$18.3K	+12,395	New
13	RCM 13 Rotella Capital Management Bellevue, Washington	$20K	+$17K	+11,510	New
14	14 Bank of Montreal Toronto, Ontario, Canada	$7K	+$2.96K	+2,000	+123%
15	15 Wells Fargo San Francisco, California	$3K	–	–	–
16	16 Creative Planning Overland Park, Kansas	$3K	+$1.33K	+900	+94%
17	17 Royal Bank of Canada Toronto, Ontario, Canada	$2K	-$12.4K	-8,354	-85%
18	18 Citigroup New York	$2K	-$78	-53	-5%
19	19 Bank of America Charlotte, North Carolina	$2K	–	–	–
20	TRCT 20 Tower Research Capital (TRC) New York	$1K	+$505	+341	+341%
21	AIG 21 American International Group New York	–	-$9K	-11,050	Closed

SPHS Hedge Fund Activity: Q4 2015 in Review

20 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Sophiris Bio, Inc. (SPHS) for Q4 2015, worth a combined $5.82M — up 687% from $739K a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new SPHS positions and 2 closed out — a net gain of 6 holders — while 6 added to existing stakes and 2 trimmed.

The largest buyer was Rock Springs Capital Management, opening a new position worth an estimated $930K. The largest seller was Royal Bank of Canada, cutting an estimated $12.4K.

20 institutional investors held Sophiris Bio, Inc. (SPHS) as of Q4 2015, up from 14 in Q3 2015.
Funds reported $5.82M of Sophiris Bio, Inc. stock for Q4 2015, up 687% quarter-over-quarter.
8 funds opened new Sophiris Bio, Inc. positions in Q4 2015 and 2 closed out, a net change of +6 holders.
The largest Sophiris Bio, Inc. buyer in Q4 2015 was Rock Springs Capital Management, an estimated $930K added.
The largest Sophiris Bio, Inc. seller in Q4 2015 was Royal Bank of Canada, an estimated $12.4K sold.

Based on aggregated 13F filings for Q4 2015.

Sophiris Bio, Inc. SPHS